Literature DB >> 16969698

Chemical and thermal stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer.

Kasper Huus1, Svend Havelund, Helle B Olsen, Marco van de Weert, Sven Frokjaer.   

Abstract

PURPOSE: To study the correlation between the thermal and chemical stability of insulin formulations with various insulin hexamer ligands.
MATERIALS AND METHODS: The thermal stability was investigated using differential scanning calorimetry (DSC) and near-UV circular dichroism (NUV-CD). The formation of chemical degradation products was studied with reversed-phase and size-exclusion chromatography and mass spectrometry.
RESULTS: An excellent correlation between the thermal stabilization by ligand binding and the deamidation of Asn(B3) was observed. The correlation between thermal stability and the formation of covalent dimer and other insulin related products was less clear. Zinc was found to specifically increase the deamidation and covalent dimer formation rate when the insulin hexamer was not further stabilized by phenolic ligand. Thiocyanate alone had no effect on the thermal stability of the insulin zinc-hexamer but significantly improved the chemical stability at 37 degrees C. At low temperatures thiocyanate induced a conformational change in the insulin hexamer. NUV-CD thermal scans revealed that this effect decreased with temperature; when the thermal denaturation temperature was reached, the effect was eliminated.
CONCLUSIONS: Thermal stability can be used to predict the rate of Asn(B3) deamidation in human insulin. Chemical degradation processes that do not rely on the structural stability of the protein do not necessarily correlate to the thermal stability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969698     DOI: 10.1007/s11095-006-9098-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

Review 1.  Secondary structure and protein deamidation.

Authors:  M Xie; R L Schowen
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

2.  Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex.

Authors:  D L Bakaysa; J Radziuk; H A Havel; M L Brader; S Li; S W Dodd; J M Beals; A H Pekar; D N Brems
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

3.  Biphasic denaturation of human albumin due to ligand redistribution during unfolding.

Authors:  A Shrake; P D Ross
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

4.  Crystallographic evidence for dual coordination around zinc in the T3R3 human insulin hexamer.

Authors:  E Ciszak; G D Smith
Journal:  Biochemistry       Date:  1994-02-15       Impact factor: 3.162

5.  Characterization of the R-state insulin hexamer and its derivatives. The hexamer is stabilized by heterotropic ligand binding interactions.

Authors:  M L Brader; N C Kaarsholm; R W Lee; M F Dunn
Journal:  Biochemistry       Date:  1991-07-09       Impact factor: 3.162

6.  Partially folded intermediates in insulin fibrillation.

Authors:  Atta Ahmad; Ian S Millett; Sebastian Doniach; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2003-10-07       Impact factor: 3.162

7.  Improved insulin stability through amino acid substitution.

Authors:  D N Brems; P L Brown; C Bryant; R E Chance; L K Green; H B Long; A A Miller; R Millican; J E Shields; B H Frank
Journal:  Protein Eng       Date:  1992-09

8.  Moisture-induced aggregation of lyophilized insulin.

Authors:  H R Costantino; R Langer; A M Klibanov
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

9.  Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.

Authors:  J Brange; L Langkjaer
Journal:  Acta Pharm Nord       Date:  1992

10.  Insulin aspart (AspB28 human insulin) derivatives formed in pharmaceutical solutions.

Authors:  Mette Uve Jars; Aage Hvass; Dorte Waaben
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

View more
  7 in total

Review 1.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

2.  Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devices.

Authors:  Jason Li; Michael K Chu; Brian Lu; Sako Mirzaie; Kuan Chen; Claudia R Gordijo; Oliver Plettenburg; Adria Giacca; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

3.  Effect of ethylenediamine on chemical degradation of insulin aspart in pharmaceutical solutions.

Authors:  Christian Poulsen; Dorte Jacobsen; Lisbeth Palm
Journal:  Pharm Res       Date:  2008-07-08       Impact factor: 4.200

4.  Effects of hydroxylpropyl-β-cyclodextrin on in vitro insulin stability.

Authors:  Liefeng Zhang; Wenjie Zhu; Lingling Song; Yifan Wang; Hui Jiang; Suyun Xian; Yong Ren
Journal:  Int J Mol Sci       Date:  2009-05-06       Impact factor: 6.208

5.  Calorimetric Study of Helix aspersa Maxima Hemocyanin Isoforms.

Authors:  Svetla Todinova; Yuliana Raynova; Krassimira Idakieva
Journal:  J Anal Methods Chem       Date:  2018-03-04       Impact factor: 2.193

6.  Heat-stability study of various insulin types in tropical temperature conditions: New insights towards improving diabetes care.

Authors:  Beatrice Kaufmann; Philippa Boulle; Flavien Berthou; Margot Fournier; David Beran; Iza Ciglenecki; Malcolm Townsend; Guillaume Schmidt; Maya Shah; Susanna Cristofani; Philippe Cavailler; Michelangelo Foti; Leonardo Scapozza
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

7.  Insight into the structural and biological relevance of the T/R transition of the N-terminus of the B-chain in human insulin.

Authors:  Lucie Kosinová; Václav Veverka; Pavlína Novotná; Michaela Collinsová; Marie Urbanová; Nicholas R Moody; Johan P Turkenburg; Jiří Jiráček; Andrzej M Brzozowski; Lenka Žáková
Journal:  Biochemistry       Date:  2014-05-22       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.